Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...

Vivo has a similar practice, but it looks like they’re slowly consolidating it with the global rollout of OriginOS 6. Vivo ...

Google’s third attempt at making a foldable sees it get a few things right. Here's our Pixel 10 Pro Fold review.